We are the
International Bladder Cancer GroupFrom clinical trials to consensus guidelines, we unite global experts to shape evidence-based treatment for bladder cancer.
About Us
Driving Global Standards in Bladder Cancer Care
The International Bladder Cancer Group (IBCG) is a global consortium of experts committed to improving outcomes for patients with bladder cancer. Through critical evaluation of data, consensus-building, and educational initiatives, we guide clinical practice and shape international standards in bladder cancer care.
20+
Years
Mission
The mission of the IBCG is two-pronged
To improve outcomes of patients suffering from bladder cancer through critical evaluation and leveraging of existing data to drive evidence-based treatment.
To develop practical educational tools that are applicable to the global urological community and thus enhance the care of patients with bladder cancer on a global level.
Meet The Members: Contributors from Around the Globe
Our Trusted Collaborations
Through global collaboration, strategic alliances, and shared purpose, we drive progress in bladder cancer research and treatment – working together to improve outcomes for patients worldwide.
Announcements
New IBCG Trainee Membership Category
Launch of a new Trainee Membership category within the International Bladder Cancer Group (IBCG)
IBCG 2025 Travel Award for Fellows and Early-Career Faculty
IBCG 2025 Travel Award to support outstanding fellows and early-career academic faculty
IBCG 2025 Retreat
August 21 – August 23
The 3rd Annual International Bladder Cancer Group (IBCG) Retreat was held in Houston from August 21–23, 2025. This meeting once again demonstrated the prestige and unique role of the IBCG in shaping the future of bladder cancer research and care.